Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about unsupported drug price hikes, an annual HIV prevention shot, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about CVS dropping Humira coverage, pharma layoffs, and more - about 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - about 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - about 1 year ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	GLP1 Agonists and Dietary Fiber May Reduce VTE Risk and Improve GVHD Outcomes - about 2 months ago
3	Kristen Monaco MedPage Today	ADA Advises Against Compounded GLP-1s; Growth Hormone Therapy Guide; T1D Outcomes Up - about 2 months ago Investigational Once-Monthly Injectable Boosts Response Rate in Acromegaly - 6 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 6 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 10 months ago Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes - 11 months ago More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk - 12 months ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - 12 months ago U.S. Rep's Death Medical Negligence? FDA Investigates GLPs; Fingerprint Mammograms - about 1 year ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - about 1 year ago Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA's Passage - about 1 year ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - about 1 year ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - about 1 year ago Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woes - about 1 year ago Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? - about 1 year ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - over 1 year ago
4	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Pharma giants vie for oral GLP-1R approval - about 2 months ago
5	The Conversation Science Alert Science news. Official account. Australia science news	Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - about 2 months ago
6	Gillian Booth MedPage Today Singer, social media manager. Philadelphia, Pennsylvania social mediamusic	IG Live December 2: The Weight of Wegovy - about 2 months ago IG Live October 23: Life in the Fast Lane With FDA's Accelerated Approvals - over 1 year ago
7	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Versant enters obesity with new startup - 2 months ago Regeneron is interested in obesity treatments that combat muscle loss - 12 months ago
8	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Novo Nordisk sells hit weight-loss drug in China—at fraction of US price - 2 months ago
9	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Pfizer’s quest for market share in the ‘high stakes battleground’ of oral GLP-1s - 3 months ago Next-gen menopause treatments have blockbuster potential. Can women, doctors and payers be convinced? - 10 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts Biologic License Application for Biosimilar Denosumab - 3 months ago Some Disease Burden of Obesity Requires Pharmacotherapy, Not Just Lifestyle Interventions - 3 months ago FDA Approves Palopegteriparatide for Treatment of Hypoparathyroidism - 5 months ago Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients - 9 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 11 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - about 1 year ago FDA Approves Vosoritide for Children With Achondroplasia - about 1 year ago

Journalists covering GHQ